What is the ticker symbol for Calidi Biotherapeutics?

Calidi Biotherapeutics trades under the ticker CLDI on AMEX.

What sector does Calidi Biotherapeutics operate in?

Calidi Biotherapeutics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze CLDI in a portfolio?

PortView shows CLDI's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Calidi Biotherapeutics (CLDI) Stock Analysis

AMEXHealthcareBiotechnology

$1.39+4.51%

1-year price historyRange $1.27 – $26.72

52-week range$1.39

$1.25$27.84

What Calidi Biotherapeutics does

Calidi Biotherapeutics, Inc. is a clinical-stage biotechnology company focused on immuno-oncology, dedicated to developing advanced immunotherapies for various cancers. The company's innovative approach centers on utilizing powerful, allogeneic (donor-derived) stem cells as specialized carriers for anti-tumor agents. This technology is being advanced to address a range of oncological conditions, including aggressive brain tumors (high-grade gliomas) and other solid malignancies. Calidi's proprietary cell-based delivery systems are expertly designed to safeguard, amplify, and boost the therapeutic effects of oncolytic viruses. This strategic delivery method aims to achieve superior treatment efficacy and enhance patient safety. The company's clinical pipeline features two primary candidates: NeuroNova, which employs allogeneic neural stem cells loaded with an oncolytic adenovirus specifically for the treatment of high-grade gliomas; and SuperNova, which utilizes allogeneic adipose-derived mesenchymal stem cells to deliver the tumor-selective CAL1 oncolytic vaccinia virus for advanced metastatic solid tumors. Established in 2014, Calidi Biotherapeutics operates out of San Diego, California.

Key metrics

Market cap

$640,007

P/E (TTM)

-0.27

EPS (TTM)

$-5.20

Beta

1.33

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$1.82

200-day avg

$8.73

52-week high

$27.84

52-week low

$1.25

CEO

Eric E. Poma

ETFs linked to CLDI

Broad-market and Healthcare sector ETFs an investor holding Calidi Biotherapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how CLDI fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze CLDI in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Calidi Biotherapeutics?: Calidi Biotherapeutics trades under the ticker CLDI on AMEX.
Which exchange is CLDI listed on?: CLDI is listed on AMEX.
What sector does Calidi Biotherapeutics operate in?: Calidi Biotherapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze CLDI in a portfolio?: PortView shows CLDI's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.